President Trump wants to lower GLP-1 prices; Novo Nordisk hires new corporate affairs lead; FDA announces priority drug review candidates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback